Dealing With the Right Side: Carcinoid Heart Disease (Withdrawn Publication. See vol. 36, pg. 4230, 2022)

被引:1
作者
Alvarez-Villegas, David [1 ]
Gimenez-Mila, Marc [2 ]
Sbraga, Fabrizio [3 ]
Camprubi, Inmaculada [1 ]
Gil, Albert [1 ]
机构
[1] Hosp Univ Bellvitge, Dept Anesthesia & Crit Care, Barcelona, Spain
[2] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Dept Anesthesia & Crit Care, Barcelona, Spain
[3] Hosp Univ Bellvitge, Dept Cardiovasc Surg & Transplantat, Barcelona, Spain
关键词
carcinoid heart disease; right ventricle; octeotride; VALVE-REPLACEMENT; SURGERY; THERAPY;
D O I
10.1053/j.jvca.2022.02.014
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:2228 / 2231
页数:4
相关论文
共 17 条
  • [1] Borna Reza M, 2017, Anesthesiol Clin, V35, P327, DOI 10.1016/j.anclin.2017.01.021
  • [2] Anesthetic Management of Patients With Carcinoid Syndrome and Carcinoid Heart Disease: The Mount Sinai Algorithm
    Castillo, Javier
    Silvay, George
    Weiner, Menachem
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2018, 32 (02) : 1023 - 1031
  • [3] Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors An Expert Statement
    Davar, Joseph
    Connolly, Heidi M.
    Caplin, Martyn E.
    Pavel, Marianne
    Zacks, Jerome
    Bhattacharyya, Sanjeev
    Cuthbertson, Daniel J.
    Dobson, Rebecca
    Grozinsky-Glasberg, Simona
    Steeds, Richard P.
    Dreyfus, Giles
    Pellikka, Patricia A.
    Toumpanakis, Christos
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (10) : 1288 - 1304
  • [4] Carcinoid syndrome, acromegaly, and hypoglycemia due to an insulin-secreting neuroendocrine tumor of the liver
    Furrer, J
    Hättenschwiler, A
    Komminoth, P
    Pfammatter, T
    Wiesli, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) : 2227 - 2230
  • [5] Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
    Kwekkeboom, Dik J.
    Krenning, Eric P.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 179 - +
  • [6] In patients with carcinoid syndrome undergoing valve replacement, will a biological valve have acceptable durability?
    Mabvuure, Nigel
    Cumberworth, Alex
    Hindocha, Sandip
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 15 (03) : 467 - 471
  • [7] Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients
    Massimino, Kristen
    Harrskog, Ola
    Pommier, Suellen
    Pommier, Rodney
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (08) : 842 - 846
  • [8] A 5-decade analysis of 13,715 carcinoid tumors
    Modlin, IM
    Lye, KD
    Kidd, M
    [J]. CANCER, 2003, 97 (04) : 934 - 959
  • [9] Update in carcinoid heart disease-the heart of the matter
    Oleinikov, Kira
    Korach, Amit
    Planer, David
    Gilon, Dan
    Grozinsky-Glasberg, Simona
    [J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2021, 22 (03) : 553 - 561
  • [10] Carcinoid Heart Disease
    Palaniswamy, Chandrasekar
    Frishman, William H.
    Aronow, Wilbert S.
    [J]. CARDIOLOGY IN REVIEW, 2012, 20 (04) : 167 - 176